The Effect of a Bioactive Fabric Sleeve
Launched by STANFORD UNIVERSITY · Jan 22, 2024
Trial Information
Current as of July 01, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a special fabric sleeve on arm soreness in collegiate baseball players after pitching. It's common for pitchers to experience soreness in their throwing arm, especially in an area called the flexor pronator mass, after games. The study aims to find out if wearing a bioactive fabric sleeve helps reduce this soreness compared to a regular sleeve. The sleeve is designed to potentially improve how the cells in the arm function, which may help with recovery.
To participate in this trial, players must be male members of the Stanford baseball team. There are no specific exclusions, so if you're on the team, you might be eligible to take part. If you join, you can expect to wear either the bioactive sleeve or a control sleeve after games and report on your soreness the next day. This research could provide valuable insights into better recovery methods for athletes during the baseball season.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Stanford Baseball Player
- Exclusion Criteria:
- • None
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Trial Officials
Michael Freehill, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported